hotspot -WSS

hotspot

author：leisure time 2025-10-01 20:15:53 - browse：1

Astrazeneca office building -- health policy coverage from STAT — AstraZeneca is suing the Biden administration to stop a new Medicare drug price negotiation program. Adobe

WASHINGTON — AstraZeneca is the sixth drugmaker to pile on a legal challenge to the Biden administration’s drug pricing reform law.

The Medicare drug price negotiation program created in the Inflation Reduction Act is set to kick off in the next week, as officials will release the names of the first 10 medicines that will be selected for the program. Medicines are eligible for selection if they are one of the highest-spend drugs for Medicare, and they have no generic competition.

AstraZeneca makes drugs that could be selected for the list, and asked a Delaware district court judge to rule that Medicare acted illegally and that the law is unconstitutional.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： The surgeon had a dilemma only a Nazi medical text could resolve

WSS

White House finalizes ITC's import ban of latest Apple Watches

AdventHealth escalates lawsuit against insurance vendor Multiplan

Burning questions for the 2024 JPM Healthcare Conference

UCB departs biotech trade group BIO

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

FDA clears AI tool for detecting skin cancer

Wikipedia

hotspot

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare Advantage today, explained in one chart

Duchenne breakthrough therapy leaves behind pioneering families

How digital therapeutics firms are pivoting after Pear's bankruptcy

The high cost of giving birth even with insurance

The tragedy of Johnson & Johnson’s Covid vaccine

Moonlake's readout produced a cash windfall. Risks remain

Ahead of JPM, here's who's profiting most in health care

Medical records are filled with copy

Feng Zhang CRISPR delivery startup lays off quarter of staff

Wikipedia

Independent physicians launch a new lobbying group

3 medical device trends to watch in 2024

Think you might have Covid

3 medical device trends to watch in 2024

Feng Zhang CRISPR delivery startup lays off quarter of staff

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Wikipedia

focus

explore

focus